These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24575266)

  • 1. Premarital Screening of Beta Thalassemia Minor in north-east of Iran.
    Hashemizadeh H; Noori R
    Iran J Ped Hematol Oncol; 2013; 3(1):210-5. PubMed ID: 24575266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of beta-thalassemia trait in premarital screening in Al-Hassa, Saudi Arabia.
    Al-Suliman A
    Ann Saudi Med; 2006; 26(1):14-6. PubMed ID: 16521869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of premarital screening of beta-thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran.
    Karimi M; Rasekhi AR
    Haematologia (Budap); 2002; 32(2):129-33. PubMed ID: 12412732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premarital Screening is Pivotal in Reducing the Births of Babies Affected with Thalassemia Major in Iraq.
    Khoshnaw NSH; Omar JJ; Hussein ZS; Mohammed RN
    Hemoglobin; 2024 Jan; 48(1):56-59. PubMed ID: 38565325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the effect of three β-thalassemia prenatal screening strategies using in Guangdong province].
    Li B; Yin A; Luo M; Wu L; Ma Y; Wang X; Zhang X; Zhao Q
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):434-40. PubMed ID: 26311551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Couples With MCV≥80, MCH<26, HbA2<3.2, HbF<3 be Classified as Low-risk β-Thalassemia Group?
    Mirzakhani M; Tarrahi MJ; Baghersad A; Maracy MR
    J Pediatr Hematol Oncol; 2019 May; 41(4):303-306. PubMed ID: 30676434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Incidence of Minor β-thalassemia Among Individuals Participated in Premarital Screening Program in Ardabil Province: North-west of Iran.
    Fathi A; Amani F; Mazhari N
    Mater Sociomed; 2019 Dec; 31(4):294-297. PubMed ID: 32082097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of beta-thalassemia and sickle cell anemia trait in premarital screening in Konya urban area, Turkey.
    Guler E; Caliskan U; UcarAlbayrak C; Karacan M
    J Pediatr Hematol Oncol; 2007 Nov; 29(11):783-5. PubMed ID: 17984699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and spectrum of haemoglobinopathies in females of reproductive age group- A first tertiary care center experience in Punjab, North India.
    Narang V; Jain A; Grover S; Soni A; Narang M; Taneja A
    Indian J Pathol Microbiol; 2023; 66(3):564-567. PubMed ID: 37530340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premarital hemoglobinopathy screening in Kayseri: a city in Middle Anatolia region of Turkey.
    Karakukcu C; Kocer D; Altuner Torun Y; Karakukcu M; Yokus O; Ozdemir MA; Patiroglu T
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):e49-52. PubMed ID: 22246155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of beta-thalassaemia and sickle cell traits in premarital screening in Al-Qassim, Saudi Arabia.
    El-Tayeb EN; Yaqoob M; Abdur-Rahim K; Gustavson KH
    Genet Couns; 2008; 19(2):211-8. PubMed ID: 18618996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Screening and Prevention Strategies for Thalassemias and other Hemoglobinopathies of Eastern India: Experience of 18,166 cases.
    Chatterjee T; Chakravarty A; Chakravarty S
    Hemoglobin; 2015; 39(6):384-8. PubMed ID: 26428539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premarital screening of beta-thalassemia trait in the province of Denizli, Turkey.
    Keskin A; Türk T; Polat A; Koyuncu H; Saracoglu B
    Acta Haematol; 2000; 104(1):31-3. PubMed ID: 11111119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia.
    Memish ZA; Saeedi MY
    Ann Saudi Med; 2011; 31(3):229-35. PubMed ID: 21623050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Using Mean Corpuscular Volume and Mean Corpuscular Hemoglobin for Beta-thalassemia Carrier Screening in the Guangdong Population of China.
    Gu H; Wang YX; Du MX; Xu SS; Zhou BY; Li MZ
    Biomed Environ Sci; 2021 Aug; 34(8):667-671. PubMed ID: 34474730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of MCV, MCH and HbA(2) in laboratory screening of thalassemia].
    Li LY; Li Q; Song LL; Jin WJ; Ma ZH; Yu YH; Zhong M
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):96-100. PubMed ID: 22455739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-inheritance of alpha-and beta-thalassemia in Khuzestan Province, Iran.
    Rahim F; Kaikhaei B; Zandian K; Hoseini A
    Hematology; 2008 Feb; 13(1):59-64. PubMed ID: 18534068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mean corpuscular volume/mean corpuscular hemoglobin values are not reliable predictors of the β-thalassemia carrier status among healthy diverse populations of Himachal Pradesh, India.
    Bharti OK; Sood RK; Sharma HR; Kaur H; Minhas V; Chauhan R; Nigam N; Phull A
    Asian J Transfus Sci; 2020; 14(2):172-178. PubMed ID: 33767545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte Indices and Hemoglobin Analysis for α-Thalassemia Screening in an Area with High Carrying Rate.
    Zheng L; Huang H; Wu X; Shen Q; Chen M; Wang M; Su L; Xu L
    Indian J Hematol Blood Transfus; 2022 Apr; 38(2):352-358. PubMed ID: 35496953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte indices in a large cohort of β-thalassemia carrier: Implication for population screening in an area with high prevalence and heterogeneity of thalassemia.
    Singha K; Taweenan W; Fucharoen G; Fucharoen S
    Int J Lab Hematol; 2019 Aug; 41(4):513-518. PubMed ID: 31099487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.